About three years after Corti's 400 mio. kr. B round, Andreas Cleve announced a significant shift in the company's strategic direction. Cleve disclosed that Corti has eliminated 80% of its revenue-generating business activities. The firm's focus has transitioned from being an AI assistant for clinicians to developing clinical AI infrastructure for healthcare products.
This change means that Corti is now concentrating on building the essential AI frameworks necessary for healthcare products, indicating a fundamental reevaluation of its role in the evolving market. Cleve emphasized that this pivot is a crucial adaptation in light of anticipated transformations in the healthcare landscape due to AI advancements.
The implications of this transition may define Corti's relevance and sustainability as AI reshapes the healthcare value chain.